Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases
Sruthi Vijaya Retnakumar(Centre National de la Recherche Scientifique), Sylviane Muller(Centre National de la Recherche Scientifique)
Cited by 23
Related Papers
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751
Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo
|Cells|2020|44
Long COVID-19 autoantibodies and their potential effect on fertility
|Frontiers in Immunology|2025|4